Impact of tumor size and location on lung dose difference between stereotactic body radiation therapy techniques for non-small cell lung cancer

被引:2
作者
Jang, Seong Soon [1 ]
Shin, Yohan [2 ]
Park, Suk Young [3 ]
Huh, Gil Ja [1 ]
Yang, Young Jun [4 ]
机构
[1] Catholic Univ Korea, Coll Med, Dept Radiat Oncol, Seoul, South Korea
[2] Daejeon St Marys Hosp, Dept Radiat Oncol, Daejeon, South Korea
[3] Daejeon St Marys Hosp, Dept Internal Med, Daejeon, South Korea
[4] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea
关键词
IMRT; lung cancer; lung dose; SBRT; tumor size; MODULATED ARC THERAPY; CONFORMAL RADIOTHERAPY; EARLY-STAGE; PNEUMONITIS; DELIVERY;
D O I
10.1111/1759-7714.14203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background To evaluate the lung dose differences between three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiation therapy (IMRT) techniques for lung stereotactic body radiation therapy (SBRT) and the correlations with tumor characteristics, such as size and location. Methods Dosimetric comparisons between the two SBRT techniques in high- and low- to intermediate-dose regions were retrospectively performed using four planning indices and lung-dose parameters in 31 lung tumors. The magnitude of differences in these parameters was analyzed with relation to the planning target volume (PTV) and location-related parameters. Results The absolute differences between the two techniques in lung-dose parameters were small in both ipsilateral and bilateral lungs. The dosimetric differences were mainly correlated with the PTV rather than location-related parameters, with positive and negative correlations with the high-dose and intermediate-dose parameters, respectively. The distances from the ipsilateral lung centroid to the PTV center were not correlated with the differences in any of the lung-dose parameters. Additionally, the negative correlations with the MLD and V20 differences disappeared after applying a more rapid dose fall-off in the IMRT plans for tumors with small PTVs of <= 15 cc. Conclusions Lung dose differences between the 3D-CRT and IMRT techniques for lung SBRT were mainly correlated with the PTV rather than location-related parameters. Together with the dosimetric benefit in high-dose lung regions of IMRT for larger tumors, the relative increases in the MLD and V20 for small-sized tumors could be reduced by applying a more rapid dose fall-off outside the PTV.
引用
收藏
页码:3310 / 3318
页数:9
相关论文
共 22 条
  • [1] Intensity-modulated radiation therapy in non-small cell lung cancers
    Ayadi, M.
    Zahra, N.
    Thariat, J.
    Bouilhol, G.
    Boissard, P.
    Van Houtte, P.
    Claude, L.
    Mornex, F.
    [J]. CANCER RADIOTHERAPIE, 2014, 18 (5-6): : 406 - 413
  • [2] No differences in radiological changes after 3D conformal vs VMAT-based stereotactic radiotherapy for early stage non-small cell lung cancer
    Badellino, Serena
    Di Muzio, Jacopo
    Schivazappa, Giulia
    Guarneri, Alessia
    Ragona, Riccardo
    Bartoncini, Sara
    Trino, Elisabetta
    Filippi, Andrea Riccardo
    Fonio, Paolo
    Ricardi, Umberto
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1078)
  • [3] Clinical and Dosimetric Predictors of Radiation Pneumonitis in a Large Series of Patients Treated With Stereotactic Body Radiation Therapy to the Lung
    Baker, Ryan
    Han, Gang
    Sarangkasiri, Siriporn
    DeMarco, MaryLou
    Turke, Carolyn
    Stevens, Craig W.
    Dilling, Thomas J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01): : 190 - 195
  • [4] A DOSE-VOLUME ANALYSIS OF RADIATION PNEUMONITIS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH STEREOTACTIC BODY RADIATION THERAPY
    Barriger, R. Bryan
    Forquer, Jeffrey A.
    Brabham, Jeffrey G.
    Andolino, David L.
    Shapiro, Ronald H.
    Henderson, Mark A.
    Johnstone, Peter A. S.
    Fakiris, Achilles J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (01): : 457 - 462
  • [5] Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial
    Bezjak, Andrea
    Paulus, Rebecca
    Gaspar, Laurie E.
    Timmerman, Robert D.
    Straube, William L.
    Ryan, William F.
    Garces, Yolanda I.
    Pu, Anthony T.
    Singh, Anurag K.
    Videtic, Gregory M.
    McGarry, Ronald C.
    Iyengar, Puneeth
    Pantarotto, Jason R.
    Urbanic, James J.
    Sun, Alexander Y.
    Daly, Megan E.
    Grills, Inga S.
    Sperduto, Paul
    Normolle, Daniel P.
    Bradley, Jeffrey D.
    Choy, Hak
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15) : 1316 - +
  • [6] Efficacy of flattening-filter-free beam in stereotactic body radiation therapy planning and treatment: A systematic review with meta-analysis
    Dang, Thu M.
    Peters, Mitchell J.
    Hickey, Brigid
    Semciw, Adam
    [J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2017, 61 (03) : 379 - 387
  • [7] European Organization for Research and Treatment of Cancer (EORTC) recommendations for planning and delivery of high-dose, high precision radiotherapy for lung cancer
    De Ruysscher, Dirk
    Faivre-Finn, Corinne
    Moeller, Ditte
    Nestle, Ursula
    Hurkmans, Coen W.
    Le Pechoux, Cecile
    Belderbos, Jose
    Guckenberger, Matthias
    Senan, Suresh
    [J]. RADIOTHERAPY AND ONCOLOGY, 2017, 124 (01) : 1 - 10
  • [8] Radiotherapy With Curative Intent in Patients With Early-stage, Medically Inoperable, Non-Small-cell Lung Cancer: A Systematic Review
    Falkson, Conrad B.
    Vella, Emily T.
    Yu, Edward
    El-Mallah, Medhat
    Mackenzie, Robert
    Ellis, Peter M.
    Ung, Yee C.
    [J]. CLINICAL LUNG CANCER, 2017, 18 (02) : 105 - +
  • [9] Fitzgerald R, 2017, J MED IMAGING RADIAT, V48, P360, DOI 10.1016/j.jmir.2017.05.003
  • [10] Stereotactic Body Radiotherapy: Volumetric Modulated Arc Therapy Versus 3D Non-coplanar Conformal Radiotherapy for the Treatment of Early Stage Lung Cancer
    Herbert, C.
    Kwa, W.
    Nakano, S.
    James, K.
    Moiseenko, V.
    Wu, J.
    Schellenberg, D.
    Liu, M.
    [J]. TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2013, 12 (06) : 511 - 516